Standard Antifungal Therapy for Pulmonary Cryptococcosis to Improve Prognosis – Authors' Reply

The Lancet Infectious Diseases - United Kingdom
doi 10.1016/s1473-3099(19)30628-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Standard Antifungal Therapy for Pulmonary Cryptococcosis to Improve Prognosis

The Lancet Infectious Diseases
Infectious Diseases
2019English

Prognosis in Diabetic Nephropathy: Authors' Reply

BMJ
1989English

Therapy for Prostate Cancer: The Authors Reply

Health Affairs
MedicineHealth Policy
2012English

Reply: Rationale for Anticoagulant Therapy of Pulmonary Fibrosis

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2014English

Authors' Reply to Nussey

British Medical Journal
Medicine
2013English

Disseminated Cryptococcosis Presenting With Adrenal Insufficiency and Meningitis: Resistant to Prolonged Antifungal Therapy but Responding to Bilateral Adrenalectomy.

Internal Medicine
Internal MedicineMedicine
1992English

Mechanisms of Pulmonary Hypertension in Bordetella Pertussis* Authors' Reply

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
2003English

Combination Therapy for Bloodstream Infections With Carbapenemase-Producing Enterobacteriaceae – Authors' Reply

The Lancet Infectious Diseases
Infectious Diseases
2017English

Editorial: Latent Class Analysis to Improve Confidence in the Diagnosis of IBS - Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy